• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估新型诊断测试的信息价值方法

Value of information methods for assessing a new diagnostic test.

作者信息

Chen Maggie Hong, Willan Andrew R

机构信息

Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

出版信息

Stat Med. 2014 May 20;33(11):1801-15. doi: 10.1002/sim.6085. Epub 2014 Jan 9.

DOI:10.1002/sim.6085
PMID:24403241
Abstract

Value-of-information methods are applied to assess the evidence in support of a new diagnostic test and, where the evidence is insufficient for decision making, to determine the optimal sample size for future studies. Net benefit formulations are derived under various diagnostic and treatment scenarios. The expressions for the expected opportunity loss of adopting strategies that include the new test are given. Expressions for the expected value of information from future studies are derived. One-sample and two-sample designs, with or without known prevalence, are considered. An example is given.

摘要

信息价值方法被用于评估支持新诊断测试的证据,并且在证据不足以进行决策时,确定未来研究的最佳样本量。在各种诊断和治疗场景下推导净效益公式。给出了采用包含新测试的策略时预期机会损失的表达式。推导了未来研究信息期望值的表达式。考虑了有或无已知患病率的单样本和两样本设计。给出了一个示例。

相似文献

1
Value of information methods for assessing a new diagnostic test.评估新型诊断测试的信息价值方法
Stat Med. 2014 May 20;33(11):1801-15. doi: 10.1002/sim.6085. Epub 2014 Jan 9.
2
Optimal sample size determinations from an industry perspective based on the expected value of information.从行业角度基于信息期望值确定最优样本量。
Clin Trials. 2008;5(6):587-94. doi: 10.1177/1740774508098413.
3
Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods.使用信息价值法确定多阶段随机临床试验的最佳样本量。
Clin Trials. 2008;5(4):289-300. doi: 10.1177/1740774508093981.
4
The cost-effectiveness of diagnostic strategies in patients with suspected pulmonary embolism.疑似肺栓塞患者诊断策略的成本效益
Health Econ. 1996 Jul-Aug;5(4):307-18. doi: 10.1002/(SICI)1099-1050(199607)5:4<307::AID-HEC214>3.0.CO;2-4.
5
Sample size determination for cost-effectiveness trials.成本效益试验的样本量确定。
Pharmacoeconomics. 2011 Nov;29(11):933-49. doi: 10.2165/11587130-000000000-00000.
6
Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods.从工业角度使用信息价值方法确定多阶段适应性随机临床试验的最佳样本量。
Clin Trials. 2013 Feb;10(1):54-62. doi: 10.1177/1740774512467404. Epub 2012 Dec 21.
7
Assessing the gain in diagnostic performance when combining two diagnostic tests.评估两种诊断测试联合使用时诊断性能的提升情况。
Stat Med. 2002 Sep 15;21(17):2527-46. doi: 10.1002/sim.1227.
8
A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.一种行为贝叶斯方法在临床试验中用于确定考虑疗效和安全性的样本量:处理组中不平衡的样本量。
Stat Methods Med Res. 2011 Aug;20(4):389-400. doi: 10.1177/0962280209358131. Epub 2010 Mar 11.
9
[Considerations on the information content of diagnostic tests (author's transl)].关于诊断试验信息含量的思考(作者译)
Wien Klin Wochenschr. 1976 Jul 16;88(14):460-3.
10
Predictive value and efficiency of hematology data.血液学数据的预测价值与效率
Blood Cells. 1980;6(2):185-97.

引用本文的文献

1
A simple framework to identify optimal cost-effective risk thresholds for a single screen: Comparison to Decision Curve Analysis.一种用于确定单一筛查最佳成本效益风险阈值的简单框架:与决策曲线分析的比较。
J R Stat Soc Ser A Stat Soc. 2021 Jul;184(3):887-903. doi: 10.1111/rssa.12680. Epub 2021 Mar 23.
2
How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through.如何解释 AUC 随着额外风险预测标志物的增加而略有增加:决策分析派上用场。
Stat Med. 2014 Sep 28;33(22):3946-59. doi: 10.1002/sim.6195. Epub 2014 May 13.